RYSGX | VISGX | RYSGX / VISGX | |
Total Expense Ratio | 1.55 | 0.19 | 816% |
Annual Report Gross Expense Ratio | 1.59 | 0.19 | 837% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | -10.949 | -15.433 | 71% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.9M | 33.7B | 0% |
Annual Yield % from dividends | 0.03 | 0.46 | 6% |
Returns for 1 year | -12.51 | -1.08 | 1,153% |
Returns for 3 years | -9.85 | 0.76 | -1,293% |
Returns for 5 years | -3.33 | 43.86 | -8% |
Returns for 10 years | -23.89 | 79.19 | -30% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTAX | 23.78 | 0.38 | +1.62% |
Fidelity Advisor Biotechnology A | |||
GNXIX | 12.38 | 0.10 | +0.81% |
AlphaCentric Robotics and Automation I | |||
DAINX | 17.48 | 0.12 | +0.69% |
Dunham International Stock A | |||
MNBIX | 18.69 | -0.01 | -0.05% |
Manning & Napier Pro-Blend Extnd Term I | |||
LGLRX | 37.62 | -0.05 | -0.13% |
Lord Abbett Growth Leaders R3 |